Aim To determine the effect of roselle (Hibiscus sabdariffa) petals in dextran sodium sulfate (DSS)-induced colitis model by measuring pro-inflammatory cytokines expressions (IL-6, and TNF-α), anti-inflammatory cytokine expression (IL-10) and histological colitis inflammation score (HCIS). Methods This study was conducted in two phases. For the first phase, five DSS-induced colitis mice were sacrificed (group 1) and compared with six healthy mice (group 2) after five-cycle induction (70 days). For the second phase, roselle-treated DSS-induced colitis mice were sacrificed on day 7, 14, 21, and 28 after induction and compared with mesalazine-treated DSS-induced colitis mice. Expressions of IL-6, TNF-α, and IL-10 were determined by immunohistochemistry and HCIS were assessed by two experienced pathologists. Results The expressions of IL-6, TNF-α, and IL-10, and HCIS in DSS-induced colitis mice were increased compared with control. The expressions of IL-6, TNF-α were significantly higher in roselle-treated group on day 7 and 14, but not on day 21 and 28, whereas, the expression of IL-10 was significantly lower only on day 7 compared with mesalazine-treated group. The inflammation was higher in roselle-treated group assessed by using HCIS. Compared to day 0, the reduction of HCIS was significant in roselle-treated and mesalazine-treated groups. Conclusion Roselle flower petal can attenuate the inflammation in DSS-induced colitis in mice. The extract of roselle can be given as an adjuvant therapy to the first-line therapy to enhance anti-inflammatory effect by increasing expression of anti-inflammatory cytokines and decreasing pro-inflammatory cytokines.
Anokwuru C, Esiaba I, Ajbaye O, Adesuyi A. Polyphenolic content and antioxidant activity of hibiscus sabdariffa calyx. Res J Med Plant 2011:557–66.
2
Ham M, Moss A. Mesalamine in the treatment and maintenance of remission of ulcerative colitis. Expert Rev Clin Pharmacol 2012:113–23.
3
Fakeye T. Toxicity and immunomodulatory activity of fractions of Hibiscus sabdariffa Linn (family Malvaceae) in animal models. Afr J Tradit Complem 2008:394–8.
4
Poritz L, Garver K, Green C, Fitzpatrick L, Ruggiero F, Koltun W. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. J Surg Res 2007:12–9.
5
Yuan B, Zhou S, Lu Y, Liu J, Wan J, Wang H, et al. Changes in the expression and distribution of claudins, increased epithelial apoptosis, and a mannan-binding lectin-associated immune response lead to barrier dysfunction in dextran sodium sulfate-induced rat colitis. Gut Liver 2015:734–40.
6
Eichele D, Kharbanda K. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol 2017:6016–29.
7
Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007:514–21.
8
Jammal M, Da Silva A, A, Filho M, De Castro Côbo A, Adad E, et al. Immunohistochemical staining of tumor necrosis factor-α and interleukin-10 in benign and malignant ovarian neoplasms. Oncol Lett 2015:979–83.
9
Laroui H, Ingersoll S, Liu H, Baker M, Ayyadurai S, Charania M, et al. Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon. PLoS One 2012:32084.
10
Laurence D, Bacharach A. Evaluation of drug activities: pharmacometrics 1964.
11
Xu Q, Katakura Y, Yamashita M, Fang S, Tamura T, Matsumoto S, et al. IL-10 augments antibody production in in vitro immunized lymphocytes by inducing a Th2-type response and B cell maturation. Biosci Biotech Bioch 2004:2279–84.
12
Fakeye T, Pal A, Khanuja S. Anxiolytic and sedative effects of extracts of Hibiscus sabdariffa Linn (family Malvaceae). Afr J Med Med Sci 2008:49–54.
13
Chang Y-C, Huang H-P, Hsu J-D, Yang S-F, Wang C-J. Hibiscus anthocyanins rich extract-induced apoptotic cell death in human promyelocytic leukemia cells. Toxicol Appl Pharm 2005:201–12.
14
Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol 2018:305–53.
15
Ilodibia C, Achebe U, Arubalueze C, Ibeh E. A comparative study on morphology, mineral and vitamin compositions of two variants of Hibiscus sabdariffa (L.). Arch Agri Environ Sci 2019:50–6.
16
Da-Costa-Rocha I, Bonnlaender B, Sievers H, Pischel I, Heinrich M. Hibiscus sabdariffa L. -A phytochemical and pharmacological review. Food Chem 2014:424–43.
17
Zhang H, Wang L, Li C, Yu Y, Yi Y, Wang J, et al. Exosome-induced regulation in inflammatory bowel disease. Front Immunol 2019:1464.
18
Nielsen O, Seidelin J, Munck L, Rogler G. Use of biological molecules in the treatment of inflammatory bowel disease. J Intern Med 2011:15–28.
19
Williams C, Panaccione R, Ghosh S, Rioux K. Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease. Therap Adv Gastroenterol 2011:237–48.
20
Liu B, Tonkonogy S, Sartor R. Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice. Gastroenterology 2011:653–62.
21
Keubler L, Buettner M, Häger C, Bleich A. A multihit model: colitis lessons from the interleukin-10-deficient mouse. Inflamm Bowel Dis 2015:1967–75.
22
Barman S, Kayama H, Okuzaki D, Ogino T, Osawa H, Matsuno H, et al. Identification of a human intestinal myeloid cell subset that regulates gut homeostasis. Int Immunol 2016:533–45.
23
Strober W, Fuss I. Pro-inflammatory cytokines in the pathogenesis of IBD. Gastroenterology 2011:1756–67.
24
Műzes G, Molnár B, Tulassay Z, Sipos F. Changes of the cytokine profile in inflammatory bowel diseases. World J Gastroenterol 2012:5848–61.
25
Bamias G, Kaltsa G, Ladas S. Cytokines in the pathogenesis of ulcerative colitis. Discovery Medicine 2011:459–67.
26
Sun M, He C, Cong Y, Liu Z. Regulatory immune cells in regulation of intestinal inflammatory response to microbiota. Mucosal Immunol 2015:969–78.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
